An elevated TRIM21 mRNA expression level was associated with a longer relapse-free survival time in breast cancer and basal-like breast cancer (Fig. 1A) but no association in other subtype breast cancers (Supplementary Fig. 1). Here, TRIM21 is linked to breast cancer.